Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-08
2011-03-08
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S369000, C514S370000, C514S374000, C514S376000, C514S377000
Reexamination Certificate
active
07902236
ABSTRACT:
The present invention is directed to compounds of formula (I)wherein variables W, X, Y, D, A, n, R1, R2and R9are as defined in the description.
REFERENCES:
patent: 2005/0228031 (2005-10-01), Bilodeau et al.
patent: WO-0230358 (2002-04-01), None
patent: WO-2004072068 (2004-08-01), None
patent: WO-2004110350 (2004-12-01), None
patent: WO-2006044527 (2006-04-01), None
Caterina et al., “Impaired Nociception and Pain Sensation in Mice Lacking the Capsaicin Receptor,” Science, 2000, 306-313, vol. 288.
Davis et al., “Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia,” (Binary/Image), 2000, 183-187, vol. 405.
Fowler, C. “Intravesical Treatment of Overactive Bladder,” Urology, 2000, 60-64, vol. 55.
International Search Report for application No. PCT/US2006/0018256, Mailed on Oct. 26, 2006, 2 pages.
Nolano et al., “Topical Capsaicin in Humans: Parallel Loss of Epidermal Nerve Fibers and Pain Sensation,” (Binary/Image), 1999, 135-145, vol. 81.
Pircio, A.W. et al., “A New Method for the Evaluation of Analgesic Activity Using Adjuvant-Induced Arthritis in the Rat,” Eur Journal of Pharmacology, 1975, 207-215, vol. 31.
Rasmussen and Bowadt. “Ketene Chemistry 2 A General Procedure for the Synthesis of 2-Alkoxycyclopropane-carboxylic Esters and Acids Starting from Aldehydes and Ketene,” Synthesis, 1989, 114-117.
Wolff “Burger's Medicinal Chemistry”, 1994, 5th Ed, vol. 1, 975-977.
Fernando Dilinie P.
Gomtsyan Arthur
Hsu Margaret Chi-Ping
Koenig John R.
Lee Chih-Hung
Abbott Laboratories
Anderson Rebecca L
Parial Andrew M.
Shterengarts Samantha L
LandOfFree
Antagonists of the vanilloid receptor subtype 1 (VR1) and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antagonists of the vanilloid receptor subtype 1 (VR1) and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists of the vanilloid receptor subtype 1 (VR1) and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2675047